血液系统恶性肿瘤靶向及免疫治疗

1. Eray Yihui Zhou, Fan Yu, Yanying Wang, Yalan Bi, Hsiaohan Tuan, Yuehua Huang, Bianhong Wang, Jingxian Li, Hongfang Yin, Lihong Li*, Yi Zhao*.Clinical and pathological evaluation of cladribine treatment response in a case series of patients with xanthoma disseminatum. Eur J Dermatol. 2023 Jun 1;33(3):270-279. doi: 10.1684/ejd.2023.4502.

2. Yuehua Huang, Yanying Wang, Fan Yu, Xuehan Mao, Bianhong Wang, Jingxian Li, Lihong Li*. Case Report: Therapeutic Use of Ibrutinib in a Patient With Schnitzler Syndrome. Front Immunol. 2022 Apr 20;13:894464. doi: 10.3389/fimmu.2022.894464. eCollection 2022.

3. 于凡，王燕婴，黄月华，李昕权，于卓.表皮生长因子受体酪氨酸激酶抑制剂致间质性肺炎后成功再用同类药一例并文献复习. 肿瘤研究与临床，2019; 31(10): 712-714.

4. Yu F, Huang Y, Wang Y, Yu Z, Li X, Dong J. Very late onset post-transplant diffuse large B cell lymphoma in a liver transplant recipient with hepatitis B: A case report. Medicine (Baltimore). 2018 Nov;97(44):e13063. IF: 2.028.

5. 于凡，王燕婴，黄月华，于卓，李昕权. 肺霍奇金淋巴瘤一例并文献复习. 白血病·淋巴瘤，2018; 27(8): 487-489.

6. 于凡，于卓，黄月华，王燕婴，李昕权. 肝癌肝移植后弥漫大B细胞淋巴瘤一例并文献复习. 肝癌电子杂志，2017,4,(3):29-31.

7. Yu F, Du Y, Han B. A comparative analysis of clinical characteristics of patients with paroxysmal nocturnal hemoglobinuria between Asia and Europe/America. Int J Hematol. 2016 Jun;103(6):649-54. IF: 1.846.

8. 于凡，李承文，魏辉，刘旭平，林冬，贡金英，秦爽，徐方运，秘营昌，王建祥。联合常规细胞遗传学检查和多重荧光原位杂交技术确定急性白血病患者复杂核型异常。中华血液学杂志，2010；5（31）：289-293。

9. 于凡，林冬，周春林，秘营昌，王迎，付明伟，刘兵城，魏辉，卞寿庚，王建祥。老年急性髓系白血病的特点及疗效分析。临床血液学杂志，2010；9（23）：513-516。

10. Long Z, Yu F, Du Y, Li H, Chen M, Zhuang J, Han B. Successful treatment of refractory/relapsed acquired pure red cell aplasia with sirolimus. Ann Hematol. 2018 Nov;97(11):2047-2054. IF: 2.845.

11. Li H, Wang L, Wu Y, Su L, Zhao H, Zhang Y, Wang Z, Huang D, Huang Z, Wu X, Li X, Ye F, Yu F, Liu H, Wang JW, Cong J, Sun W, Chen HR, Wang J, Han B. Very-Low-Dose Decitabine Is Effective in Treating Intermediate- or High-Risk Myelodysplastic Syndrome. Acta Haematol. 2017;138(3):168-174.IF:1.307.

12. 黄月华;王燕婴;于凡;李硕; 王莉莉.原发肠道非霍奇金淋巴瘤46例临床特点及治疗分析. 胃肠病学和肝病学杂志, 2016 , 25 (2) :198-201.

13. Eiring AM, Khorashad JS, Anderson DJ, Yu F, Redwine HM, Mason CC, Reynolds KR, Clair PM, Gantz KC, Zhang TY, Pomicter AD, Kraft IL, Bowler AD, Johnson K, Partlin MM, O'Hare T, Deininger MW. β-Catenin is required for intrinsic but not extrinsic BCR-ABL1 kinase-independent resistance to tyrosine kinase inhibitors in chronic myeloid leukemia. Leukemia. 2015 Dec;29(12):2328-37. IF:10.431.

14. Khorashad JS, Eiring AM, Mason CC, Gantz KC, Bowler AD, Redwine HM, Yu F, Kraft IL, Pomicter AD, Reynolds KR, Iovino AJ, Zabriskie MS, Heaton WL, Tantravahi SK, Kauffman M, Shacham S, Chenchik A, Bonneau K, Ullman KS, O'Hare T, Deininger MW. shRNA library screening identifies nucleocytoplasmic transport as a mediator of BCR-ABL1 kinase-independent resistance. Blood. 2015 Mar 12;125(11):1772-81. IF: 10.452.

15. Zhi L, Wang M, Rao Q, Yu F, Mi Y, Wang J. Enrichment of N-Cadherin and Tie2-bearing CD34+/CD38-/CD123+ leukemic stem cells by chemotherapy-resistance. Cancer Lett. 2010 Oct 1;296(1):65-73. IF: 4.864.

学术荣誉及奖励

2013年获北京清华长庚医院第一届青年教师讲课比赛三等奖；

2015年获评北京清华长庚医院“住院医师心中的好老师”称号；

2015年中华医学会第15次全国红细胞疾病（贫血）学术会议论文交流优秀奖；

2020年度北京清华长庚医院工作中做出重大贡献，记功；

2020年全国血液病实战大赛优秀奖；

2021年获评北京清华长庚医院“优秀工作者”；

2022年获评北京清华长庚医院“服务标兵”。

学术任职

北京整合医学学会血液肿瘤专业委员会委员

北京围手术期医学研究会血液专业委员会委员

北京癌症防治学会淋巴瘤免疫治疗专业委员会委员